LENSAR, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
LNSR Nasdaq 3841 www.lensar.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for LENSAR, Inc.

LENSAR Reports First Quarter 2025 Results and Provides Business Update - May 8th, 2025 11:00 am
Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit - Mar 25th, 2025 1:00 pm
Alcon Agrees to Acquire LENSAR, Inc. - Mar 24th, 2025 12:00 pm
LENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Feb 28th, 2025 7:17 am
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - Feb 27th, 2025 12:00 pm
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Feb 4th, 2025 12:33 am
LENSAR, Inc. (NASDAQ:LNSR) surges 13%; retail investors who own 40% shares profited along with institutions - Jan 25th, 2025 12:15 pm
LENSAR, Inc.'s (NASDAQ:LNSR) Path To Profitability - Dec 20th, 2024 10:46 am
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day - Nov 26th, 2024 1:00 pm
LENSAR Third Quarter 2024 Earnings: Beats Expectations - Nov 9th, 2024 1:35 pm
LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - Nov 8th, 2024 7:14 am
LENSAR Reports Third Quarter 2024 Results and Provides Business Update - Nov 7th, 2024 12:00 pm
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 - Oct 31st, 2024 11:00 am
LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans - Oct 30th, 2024 1:16 pm
Lensar announces more than 1M procedures completed with cataract laser systems - Oct 9th, 2024 12:15 pm
One Millionth Procedure Completed Using LENSAR’s Cataract Laser Systems - Oct 8th, 2024 12:00 pm
LENSAR to Participate in Two Upcoming Investor Conferences - Sep 4th, 2024 12:00 pm
LENSAR Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Aug 10th, 2024 1:03 pm
LENSAR Reports Second Quarter 2024 Results and Provides Business Update - Aug 8th, 2024 11:00 am
LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union - Aug 7th, 2024 11:00 am